These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Dolan MS; Riad K; El-Shafei A; Puri S; Tamirisa K; Bierig M; St Vrain J; McKinney L; Havens E; Habermehl K; Pyatt L; Kern M; Labovitz AJ Am Heart J; 2001 Nov; 142(5):908-15. PubMed ID: 11685180 [TBL] [Abstract][Full Text] [Related]
4. Assessment of left ventricular wall motion and delineation of the endocardial border after intravenous injection of Infoson during dobutamine stress echocardiography. Ikonomidis I; Holmes E; Narbuvold H; Bolstad B; Muan B; Nihoyannopoulos P Coron Artery Dis; 1998; 9(9):567-76. PubMed ID: 9861518 [TBL] [Abstract][Full Text] [Related]
5. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose]. Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717 [TBL] [Abstract][Full Text] [Related]
6. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization. Yvorchuk KJ; Sochowski RA; Chan KL J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629 [TBL] [Abstract][Full Text] [Related]
7. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522 [TBL] [Abstract][Full Text] [Related]
8. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. Porter TR; Xie F; Kricsfeld A; Chiou A; Dabestani A J Am Coll Cardiol; 1994 May; 23(6):1440-3. PubMed ID: 8176104 [TBL] [Abstract][Full Text] [Related]
9. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity. Leischik R; Beller KD; Erbel R Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247 [TBL] [Abstract][Full Text] [Related]
10. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex. Gandhok NK; Block R; Ostoic T; Rawal M; Hickle P; Devries S; Feinstein SB J Am Soc Echocardiogr; 1997; 10(1):25-30. PubMed ID: 9046490 [TBL] [Abstract][Full Text] [Related]
11. [Assessment of left ventricular volume by contrast echocardiography]. Iwamori K; Ishikawa K Nihon Rinsho; 1998 Apr; 56(4):926-9. PubMed ID: 9577610 [TBL] [Abstract][Full Text] [Related]
12. Does second harmonic imaging improve left ventricular endocardial border identification at higher heart rates during dobutamine stress echocardiography? Sozzi FB; Poldermans D; Boersma E; Elhendy A; Bax JJ; Borghetti A; Roelandt JR J Am Soc Echocardiogr; 2000 Nov; 13(11):1019-24. PubMed ID: 11093104 [TBL] [Abstract][Full Text] [Related]
13. [Improved endocardial border delineation during dobutamine stress echocardiography using the left heart contrast medium BY 963]. Frieske R; Kühl H; Yuan D; Lepper W; Franke A; Hoffmann R Z Kardiol; 2000 Mar; 89(3):186-94. PubMed ID: 10798274 [TBL] [Abstract][Full Text] [Related]
14. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans. Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106 [TBL] [Abstract][Full Text] [Related]
15. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography]. Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037 [TBL] [Abstract][Full Text] [Related]